Researchers at the New York Blood Center have made a breakthrough in understanding the body’s autoimmune response to sickle ...

Adding talazoparib (Talzenna) to enzalutamide (Xtandi) as initial treatment for metastatic castration-resistant prostate ...

For the past month, local basketball programs have teamed up to raise awareness and spread hope for 9-year-old Autumn and ...

Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

Medically reviewed by Gagandeep Brar, MD Bone marrow is the deep, interior portion of your bone. Your bone marrow, which has ...

USA-based Agios Pharmaceuticals has announced that the ACTIVATE-Kids Phase III study of mitapivat in children aged 1 to <18 ...

The Global Mineral Supplements Market size is expected to be worth around USD 22.7 Billion by 2033, from USD 15.2 Billion in 2023, growing at a CAGR of 4.20% Lawrence John Prudour +91 91308 55334 ...

In a recent study, non-invasive prenatal testing was able to help researchers diagnose fetal anemia earlier during pregnancy.

Combining talazoparib with enzalutamide significantly improves overall survival in patients with metastatic ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

The off-the-shelf chimeric antigen receptor T-cell therapy P-BCMA-ALLO1 was shown to be safe and elicited strong anti-tumor ...

A new effort is underway to legalize not just medical marijuana but recreational use, too. But is that the best route forward ...